Ranbaxy Faces False Marking Suit Over Exelderm

Law360, New York (August 10, 2010, 1:40 PM EDT) -- Promote Innovation LLC has accused Ranbaxy Laboratories Inc. of injuring the U.S. government and stifling industry innovation by marking a line of anti-fungus products with a patent that expired in 1996.

Ranbaxy misled the public into believing the company had control over the formula for Exelderm, a cream used to treat skin infections like athlete's foot and ringworm, according to an amended complaint lodged Monday in the U.S. District Court for the Eastern District of Texas.

The updated allegations came the same day the court adopted...
To view the full article, register now.